Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.17 - $765.0 $94 - $425,340
-556 Reduced 82.25%
120 $0
Q2 2022

Aug 10, 2022

BUY
$0.27 - $0.71 $173 - $456
643 Added 1948.48%
676 $0
Q1 2022

May 04, 2022

SELL
$0.38 - $1.07 $25 - $71
-67 Reduced 67.0%
33 $0
Q3 2021

Nov 05, 2021

BUY
$2.14 - $4.95 $214 - $495
100 New
100 $0

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $122M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.